| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |